STRATA Skin Sciences (SSKN) Current Deferred Revenue (2012 - 2025)

STRATA Skin Sciences has disclosed Current Deferred Revenue across 14 years of filings, most recently posting $2.2 million for Q4 2025.

• Current Deferred Revenue for Q4 2025 came in at $2.2 million, changed 0.31% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.2 million (changed 0.31% YoY), and the FY2025 annual result was $2.2 million, changed 0.31% from the prior year.
• Current Deferred Revenue came in at $2.2 million for Q4 2025 at STRATA Skin Sciences, down from $2.6 million in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $3.8 million in Q3 2021 to a low of $2.1 million in Q4 2023.
• The 5-year median for Current Deferred Revenue is $2.4 million (2023), against an average of $2.6 million.
• Across the five-year window, Current Deferred Revenue jumped 132.84% in 2021 and retreated 25.12% in 2023, its largest moves.
• STRATA Skin Sciences' Current Deferred Revenue stood at $3.3 million in 2021, then dropped by 15.43% to $2.8 million in 2022, then declined by 23.69% to $2.1 million in 2023, then grew by 5.71% to $2.2 million in 2024, then gained by 0.31% to $2.2 million in 2025.
• The last three Current Deferred Revenue figures came in at $2.2 million (Q4 2025), $2.6 million (Q3 2025), and $2.4 million (Q2 2025), per Business Quant data.